<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75458">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02123277</url>
  </required_header>
  <id_info>
    <org_study_id>9259</org_study_id>
    <nct_id>NCT02123277</nct_id>
  </id_info>
  <brief_title>Long Term Evaluation of Tubal Expansion on Obstructive Dysfunctions of Eustachian Tube</brief_title>
  <official_title>Long Term Evaluation of Tubal Expansion on Obstructive Dysfunctions of Eustachian Tube</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aim is to evaluate the tubal score on patients who suffer from obstructive
      dysfunction of eustachian tube before and after the eustachian tube dilatation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aim is to evaluate the tubal score on patients who suffer from obstructive
      dysfunction of eustachian tube before the intervention and 12 months after the eustachian
      tube dilatation.

      This patients are refractory to the reference medical treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Tubal score</measure>
    <time_frame>at 1st day, and 2 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Eustachian Tube Disorder</condition>
  <arm_group>
    <arm_group_label>concept proof</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Balloon catheter for the Eustachian tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Balloon catheter for the Eustachian tube</intervention_name>
    <description>Balloon catheter is inserted in the Eustachian tube to dilate it.</description>
    <arm_group_label>concept proof</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients between 20 and 80 years old

          -  tubal score lower than 5

          -  patients who already used reference medical treatment

        Exclusion Criteria:

          -  patients who already do a major surgery of middle ear

          -  tympanic perforation

          -  pregnant or breastfeeding woman.

          -  patients who can't be follow during 14 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frederic VENAIL</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frederic VENAIL</last_name>
    <phone>04 67 33 68 00</phone>
    <email>f-venail@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gui de Chauliac Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34090</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic VENAIL, MD, PhD</last_name>
      <phone>33(0)467336800</phone>
      <email>f-venail@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Frederic VENAIL, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <lastchanged_date>July 20, 2015</lastchanged_date>
  <firstreceived_date>March 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
